Understanding Colorectal Cancer Screening for Ages 45-54
This observational study aims to understand why some individuals aged 45-54 have not been screened for colorectal cancer (CRC). Researchers want to identify factors within health centers and from patients' perspectives that help or hinder screening. You might be eligible if you are 45-54 years old, a patient at the health center, and have no personal or family history of CRC, inflammatory bowel disease, or high-risk cancer syndrome. The study will measure how acceptable and practical different strategies are for encouraging screening. This will be assessed over a 12-month period, from planning to evaluation. The study plans to enroll 40 participants.
- Study design
- This is an observational study that aims to enroll 40 participants. It involves interviews with patients and surveys with health center staff.
- What's involved
- Participants will be asked to take part in a one-time interview, either online or in-person.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will assess outcomes over a total of 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
CRC Screening in Unscreened Individuals 45-54
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Adjoa Anyane-Yeboa, MD, MPH · PRINCIPAL_INVESTIGATOR · Massachusetts General Hospital
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Measurement of acceptability and feasibility of implementation strategiesFrom planning to testing and evaluation and assessment of outcomes will be a total of 12 months
For our primary outcome, participants will be asked to rate the acceptability and feasibility of implementation strategies using a previously validated instrument, which the investigator previously used with CHC staff. This tool has demonstrated good internal consistency reliability (0.85 for acceptability and 0.89 for feasibility) and similarly good test-retest reliability (correlations: acceptability- 0.80; feasibility - 0.88) and validity in a known groups analysis. There are no cut off numbers for acceptability and feasibility as these are just means but higher scores reflect higher acceptability. However, our surveys will allow us to better understand our survey findings. Quantitative survey interviews will be collected after first and second cycle of testing. The surveys and interviews will be measured together as this is a mixed methods study.